Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCalidi Biotherapeutics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/14/2026 | Q1 2026 | N/A | -$6.88 | N/A | N/A | $0 |
| 03/27/2026 | Q4 2025 | -$1.56 | -$8.96 | -7.4 | N/A | $0 |
| 11/13/2025 | Q3 2025 | N/A | -$35.36 | N/A | N/A | $0 |
| 08/08/2025 | Q2 2025 | N/A | -$31.84 | N/A | N/A | $0 |
| 05/14/2025 | Q1 2025 | N/A | -$35.36 | N/A | N/A | $0 |
| 03/31/2025 | Q4 2024 | N/A | -$51.52 | N/A | N/A | $0 |
| 11/12/2024 | Q3 2024 | -$10.27 | -$124.80 | -114.53 | N/A | $0 |
| 08/13/2024 | Q2 2024 | -$17.40 | -$268.80 | -251.4 | N/A | $0 |
| 08/13/2024 | Q1 2024 | -$17.40 | -$390.72 | -373.32 | N/A | $0 |
| 12/30/2023 | Q4 2023 | N/A | -$444.80 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$271.52 | N/A | N/A | $0 |
| 06/28/2023 | Q2 2023 | N/A | -$829.44 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$432.00 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$503.04 | N/A | N/A | $0 |
| 09/28/2022 | Q3 2022 | N/A | $36.48 | N/A | N/A | $0 |
| 06/28/2022 | Q2 2022 | N/A | $278.40 | N/A | N/A | $0 |
| 03/29/2022 | Q1 2022 | N/A | $97.92 | N/A | N/A | $45.00 K |
| 12/29/2021 | Q4 2021 | N/A | $286.08 | N/A | N/A | $405.00 K |
| 09/28/2021 | Q3 2021 | N/A | -$55.68 | N/A | N/A | $0 |
| 06/29/2021 | Q2 2021 | N/A | -$0.67 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Calidi Biotherapeutics Inc Earnings: FAQ's
In the previous quarter, Calidi Biotherapeutics Inc (:CLDI) reported $-0.57 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.56 by $0.99.
The conference call for Calidi Biotherapeutics Inc's latest earnings report can be listened to online.
The conference call transcript for Calidi Biotherapeutics Inc's latest earnings report can be read online.
Calidi Biotherapeutics Inc (:CLDI) has a recorded net income of $-19,906,000.Calidi Biotherapeutics Inc has generated $-95.2 earnings per share over the last four quarters.
Calidi Biotherapeutics Inc (:CLDI) has a price-to-earnings ratio of -0.02 and price/earnings-to-growth ratio is -0.